Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
hwWFBgtj5BugdceA